Common blood pressure medication associated with poorer kidney outcomes in type 2 diabetes

by | Jun 4, 2026 | Health

Spread the love
New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already receiving modern kidney-protective treatments.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments